Expression of vasoactive intestinal peptide (VIP) receptors in human uterus

被引:24
|
作者
Bajo, AM
Juarranz, MG
Valenzuela, P
Martínez, P
Prieto, JC
Guijarro, LG [1 ]
机构
[1] Univ Alcala de Henares, Dept Bioquim & Biol Mol, Unidad Neuroendocrinol Mol, E-28871 Alcala De Henares, Spain
[2] Hosp Principe Asturias, Serv Obstet & Ginecol, E-28871 Alcala De Henares, Spain
[3] Hosp Principe Asturias, Serv Anat Patol, E-28871 Alcala De Henares, Spain
关键词
VIP receptors; adenylyl cyclase; myometrium; endometrium; leiomyoma; Fallopian tube;
D O I
10.1016/S0196-9781(00)00282-5
中图分类号
Q5 [生物化学]; Q7 [分子生物学];
学科分类号
071010 ; 081704 ;
摘要
We show the existence of functional vasoactive intestinal peptide (VIP) receptors in normal human female genital tract (endometrium, myometrium, ovary and Fallopian tube) as well as in leiomyoma (a frequent uterine pathology). The correlation between VIP binding and stimulation of adenylyl cyclase activity for all studied tissues was linear (r = 0.86) suggesting the expression of VIP receptors throughout the human female genital tract. Immunodetection of VIP receptor subtypes gave different molecular weights for VPAC(1) (47 kDa primarily) and VPAC(2) (65 kDa), which may be due to different glycosylation extents. In conclusion, this study demonstrates the expression of both subtypes of VIP receptors and their functionality in human female genital tract, suggesting that this neuropeptide could play an important physiological and pathophysiological role at this level. (C) 2000 Elsevier Science Inc. All rights reserved.
引用
收藏
页码:1383 / 1388
页数:6
相关论文
共 50 条
  • [1] Calcium signaling mediated by human receptors for vasoactive intestinal peptide (VIP).
    Mu, Y
    Xia, M
    Goetzl, EJ
    Sreedharan, SP
    FASEB JOURNAL, 1996, 10 (06): : 827 - 827
  • [2] VASOACTIVE-INTESTINAL-PEPTIDE (VIP) AND RECEPTORS IN HUMAN COLONIC CARCINOMAS
    LUO, W
    MO, RG
    CHEN, Q
    ZHOU, ZC
    HOU, X
    CHEN, YF
    BIOMEDICAL RESEARCH-TOKYO, 1992, 13 : 223 - 223
  • [3] Effect of vasoactive intestinal peptide (VIP) on cytokine production and expression of VIP receptors in thymocyte subsets
    Xin, ZC
    Jiang, XM
    Wang, HY
    Denny, TN
    Dittel, BN
    Ganea, D
    REGULATORY PEPTIDES, 1997, 72 (01) : 41 - 54
  • [4] VASOACTIVE INTESTINAL PEPTIDE (VIP) RECEPTORS THYROID MEMBRANES
    MOLINERO, P
    GUERRERO, JM
    CALVO, JR
    GOBERNA, R
    ANNALES D ENDOCRINOLOGIE, 1983, 44 (04) : A66 - A66
  • [5] ONTOGENY OF VASOACTIVE-INTESTINAL-PEPTIDE (VIP) AND RECEPTORS IN HUMAN FETAL TISSUES
    ZHENG, J
    CHEN, YF
    CAI, LM
    WANG, DT
    LIU, TH
    BIOMEDICAL RESEARCH-TOKYO, 1992, 13 : 217 - 221
  • [6] Nuclear localization of vasoactive intestinal peptide (VIP) receptors in human breast cancer
    Valdehita, Ana
    Bajo, Ana M.
    Fernandez-Martinez, Ana B.
    Isabel Arenas, M.
    Vacas, Eva
    Valenzuela, Pedro
    Ruiz-Villaespesa, Antonio
    Prieto, Juan C.
    Carmena, Maria J.
    PEPTIDES, 2010, 31 (11) : 2035 - 2045
  • [7] Embryonic expression of vasoactive intestinal peptide (VIP) and VIP receptor genes
    Waschek, JA
    Ellison, J
    Bravo, DT
    Handley, V
    JOURNAL OF NEUROCHEMISTRY, 1996, 66 (04) : 1762 - 1765
  • [8] MEMBRANE RECEPTORS FOR INTESTINAL VASOACTIVE PEPTIDE (VIP) - HORMONE AND A NEUROTRANSMITTER
    ROBBERECHT, P
    ARCHIVES INTERNATIONALES DE PHYSIOLOGIE DE BIOCHIMIE ET DE BIOPHYSIQUE, 1978, 86 (04): : 842 - 842
  • [9] EXPRESSION OF HISTAMINE AND VASOACTIVE INTESTINAL PEPTIDE (VIP) RECEPTORS IN IMMORTALIZED RAT FETAL INTESTINAL-CELLS
    EMAMI, S
    MIR, L
    CHANUT, P
    CHASTRE, E
    CHATELET, F
    FEUNTEUN, J
    GESPACH, C
    AGENTS AND ACTIONS, 1988, 23 (3-4): : 276 - 279
  • [10] Generation of monoclonal antibodies to human vasoactive intestinal peptide (VIP) 1 receptors.
    Sreedharan, SP
    Pillai, N
    Mu, Y
    Kong, Y
    Goetzl, EJ
    FASEB JOURNAL, 1998, 12 (04): : A153 - A153